Home |
Free Dividend Report |
Stock Splits Calendar |
GALE Historical Stock Prices |
Preferred Stock Newsletter |
GALE Options Chain |
GALE Message Board |
GALE (GALE) has the following price history information. Looking back at GALE historical stock prices for the last five trading days, on December 22, 2017, GALE opened at $0.28, traded as high as $0.28 and as low as $0.27, and closed at $0.28. Trading volume was a total of 730.60K shares. On December 26, 2017, GALE opened at $0.28, traded as high as $0.29 and as low as $0.27, and closed at $0.28. Trading volume was a total of 500.30K shares. On December 27, 2017, GALE opened at $0.28, traded as high as $0.29 and as low as $0.27, and closed at $0.28. Trading volume was a total of 577.40K shares. On December 28, 2017, GALE opened at $0.28, traded as high as $0.28 and as low as $0.27, and closed at $0.28. Trading volume was a total of 705.30K shares. On December 29, 2017, GALE opened at $0.29, traded as high as $0.40 and as low as $0.26, and closed at $0.26. Trading volume was a total of 20.35M shares.
GALE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into GALE shares, starting with a $10,000 purchase of GALE, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/24/2014 | |
End date: | 12/29/2017 | |
Start price/share: | $45.60 | |
End price/share: | $0.26 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.43% | |
Average Annual Total Return: | -75.39% | |
Starting investment: | $10,000.00 | |
Ending investment: | $57.05 | |
Years: | 3.68 |
GALE Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
12/22/2017 | $0.28 | $0.28 | $0.27 | $0.28 | 730.60K |
12/26/2017 | $0.28 | $0.29 | $0.27 | $0.28 | 500.30K |
12/27/2017 | $0.28 | $0.29 | $0.27 | $0.28 | 577.40K |
12/28/2017 | $0.28 | $0.28 | $0.27 | $0.28 | 705.30K |
12/29/2017 | $0.29 | $0.40 | $0.26 | $0.26 | 20.35M |
About GALE |
SELLAS Life Sciences Group is a biopharmaceutical company developing hematology and oncology therapeutics. Co.'s pipeline consists of multiple mid- to late-stage clinical assets, including its hematology asset, GALE-401, and its cancer immunotherapy programs including NeuVax (nelipepimut-S), GALE-301 and GALE-302. GALE-401 is a controlled release version of the approved drug anagrelide for the treatment of elevated platelets in patients with myeloproliferative neoplasms. NeuVax is in clinical trials in breast cancer. GALE-301 and GALE-302 have completed early stage trials in ovarian, endometrial and breast cancers. |
GALE Historical Closing Prices | |
Date | Close |
12/22/2017 | $0.28 |
12/26/2017 | $0.28 |
12/27/2017 | $0.28 |
12/28/2017 | $0.28 |
12/29/2017 | $0.26 |
Healthcare Historical Prices |
GALE is categorized under the Healthcare sector; below are some other companies in the same sector:
GALT Historical Stock Prices
Free GALE Email Alerts:
|
GALE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.